|Day Low/High||385.86 / 398.25|
|52 Wk Low/High||145.23 / 456.23|
Results on conference picks are split as hedge fund industry contends with criticism.
David Einhorn, Jim Chanos presentations close out 2106's Sohn Investment Conference.
Shares of DexCom have bounced back 15% since hitting a 52-week low early last month, yet are still down 20% so far in 2016.
A combination of price and range compression often precedes volatility squeeze breakouts.
Dexcom's Ashley Benedict shares her experience from diagnosis at age 7 to becoming an educator at the company that improved the quality of her life.
Dexcom CEO Terry Gregg reviews the tremendous growth the company saw in 2013 and how the company is improving the quality of life for diabetics. TheStreet's Jill Malandrino reports from the Nasdaq MarketSite in New York.